Navigation Links
AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
Date:5/14/2013

BETHESDA, Md., May 13, 2013 /PRNewswire-USNewswire/ -- Today, the American Gastroenterological Association announced that Takeda Pharmaceuticals U.S.A., Inc. will provide a $1.5 million unrestricted grant to the AGA Research Foundation endowment.  This grant to the AGA Research Foundation endowment funds research and discoveries in gastroenterology, and supports young investigators across the United States.

The AGA Research Foundation provides research grants to investigators in gastroenterology and hepatology.  The foundation's grants transform young researchers' lives by encouraging them to embark on and continue careers in research. Many ultimately make discoveries that improve patient care. Since 1984, the AGA has funded more than 700 scientists.

"We are proud to play a role in young investigators' ongoing research to better understand GI conditions and find innovative approaches to helping people," said Loren Laine , MD, AGAF, president of the AGA Institute. "Takeda's support of the AGA Research Foundation is a critical investment in the future of the field of gastroenterology that ensures we can continue funding research into the causes, diagnosis, prevention and treatment of digestive diseases." 

"For millions of Americans living with digestive disorders, ongoing research remains vital to expand our understanding of the conditions and hopefully improve outcomes. Generous contributions such as this one from Takeda Pharmaceuticals underscore that commitment," said David A. Peura , MD, AGAF, past president of the AGA. "With Takeda's help, we will be able to continue supporting young researchers and investigators across this therapeutic area."

About the AGA Research Foundation

The AGA Research Foundation is the foundation of the American Gastroenterological Asso
'/>"/>

SOURCE American Gastroenterological Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
5. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
6. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
7. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
8. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
11. Okuma America Chooses The Daniel Group To Provide Customer Service Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced that ... financial results after the market closes on Thursday, March ... will host a conference call with the investment community at ... 5, 2015 to discuss the results of the quarter ... the live conference call via telephone by dialing (877) 407-0784 ...
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 Every ... more research to fight heart disease.  Nevertheless, year after ... on ElectroCardioGrams (EKG) as the first test to determine ... they have chest pain or not, even though that ... occurs despite the fact that doctors know, (while most ...
(Date:2/26/2015)... MILFORD, Mass. , Feb. 26, 2015 /PRNewswire/ ... developing novel therapeutics for the treatment of Hepatitis ... announced the closing of a $22 million financing. ... of SB 9200, a novel, broad spectrum antiviral ... molecule nucleic acid hybrid (SMNH) chemistry platform, into ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... Meaningful Placebo Adjusted Weight,Loss; Obesity Program to ... /PRNewswire-FirstCall/ -- Manhattan,Pharmaceuticals, Inc. today announced results ... of oral Oleoyl-estrone (OE). The results,of both ... and the other in morbid obesity, demonstrated ...
... prompt request for meeting with FDA, SEATTLE, ... (CTI) announced today that interim results of,its ... pixantrone is,substituted for doxorubicin in standard CHOP-R ... (NHL), resulted,in essentially all patients on both ...
Cached Medicine Technology:Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy 2Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy 3Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy 4Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy 5
(Date:2/27/2015)... “ Logical Operations ” was featured on NewsWatch ... a look at the latest and coolest technology products ... reporter for NewsWatch and a technology expert, conducted the ... companies avoid cyber security threats. , If a person ... security somewhere in the headlines. Well, cyber security is ...
(Date:2/27/2015)... Raton, FL (PRWEB) February 27, 2015 ... diagnostic testing company that provides vascular, echocardiogram and ... proud to be the preferred diagnostic testing provider ... University, a coeducational public liberal arts university in ... by the Wimbledon U collegiate division, ...
(Date:2/27/2015)... 27, 2015 Mirena IUD lawsuits ( ... allegedly suffered uterine perforations and other serious harm due ... to move forward in the multicounty litigation underway in ... reports. Court records indicate that the proceeding’s 34th ... a Conference convened that same day. (In Re: Mirena ...
(Date:2/27/2015)... "After studying the benefits and risks to mom and ... repair may outweigh the risks for those moms who have ... Fetal Care Institute Director Dr. Mike Vlastos, who is ... goal of the study is to gain an understanding of ... babies." , Studies have shown that mothers with an elevated ...
(Date:2/27/2015)... Jupiter Medical Center and The Mount Sinai ... New York at Jupiter Medical Center, to enhance cardiac ... , “This innovative collaboration with Mount Sinai Heart New ... care in our very own backyard,” said John D. ... Center. “This kind of innovative thinking will transform cardiac ...
Breaking Medicine News(10 mins):Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 3Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5
... April 11 Takeda,Pharmaceutical Company Limited ("Takeda", TSE: ... offer for all outstanding shares of the,common stock ... per share. The tender offer is being made ... Takeda America Holdings,Inc., which is a wholly owned ...
... following was,issued today by the Joint Center for ... Center for Political and Economic Studies in,collaboration with ... of Latino Elected and Appointed Officials (NALEO) will,conduct ... How and Why,They are Integral to Health Equity" ...
... WASHINGTON, April 11 A Pennsylvania general,contractor for residential ... New York Presbyterian Hospital (NYPH) for his role in,a ... official at,NYPH., Aaron S. Weiner, of Meadowbrook, Pa., ... in a conspiracy that took place from,at least June ...
... Gaps that Make Breast ... of Color, BOSTON, April 11 Today, more ... Affiliate of Susan G. Komen,for the Cure(R), joined Massachusetts ... (D-10th Middlesex) and breast health,officials at the State House ...
... trigger an immune response where none existed is key to ... HIV/AIDS vaccine designed to overcome the problem of preexisting immunity ... clinical trial at Brigham and Women,s Hospital in Boston. , ... developing nations. , There will be 48 healthy volunteers taking ...
... Union-Busting Raids on SEIU Members..., LOS ... Association escalates shameful and recently violent efforts ... SEIU,local union United Healthcare Workers-West (UHW-W) still ... taking action to stop the CNA,s union-busting,tactics. ...
Cached Medicine News:Health News:Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium 2Health News:Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium 3Health News:Joint Center to Focus on Issues of Health Equity During Congressional Black Caucus Spring Health Braintrust 2Health News:Pennsylvania Contractor Pleads Guilty to Participating in Fraud Conspiracy at New York Presbyterian Hospital 2Health News:Susan G. Komen for the Cure(R) Calls on Policymakers to Address Unfairness in Breast Cancer Incidence and Mortality 2Health News:Susan G. Komen for the Cure(R) Calls on Policymakers to Address Unfairness in Breast Cancer Incidence and Mortality 3Health News:Boston Trial to Test New HIV/AIDS Vaccine 2Health News:SEIU Local Union UHW-W Refuses to Take Action With Other SEIU Local Unions Against CNA 2Health News:SEIU Local Union UHW-W Refuses to Take Action With Other SEIU Local Unions Against CNA 3
... surgical stretcher. M-701 Stretcher has a ... to 32 in., measured with a ... a high range, 28 in. to ... pad can be supplied optionally. Vinyl ...
... is a staining solution for cataract ... for performing a safe phaco-emulsification procedure. ... capsule may result in an incomplete ... of radial capsule tears and associated ...
... dye, used in matured cataract surgery, which ... enables the surgeon to see capsule ... trypan blue combined with sodium chloride and ... intraocular injection into the anterior chamber of ...
Blanket protection against heavier bleeding....
Medicine Products: